Flying The Web For News.
  • 2024 Presidential Election
    2024 Presidential Election
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BET Inhibitor VYN202

Details
Category: Globe NewsWire News Distribution Service

VYN202 has been designed to achieve class-leading potency and BD2-selectivity Trial will evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of VYN202 in healthy volunteers; top-line data expected in 2H’24


Posted: 2024-06-13 13:02:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Tags

press | release | vyne | therapeutics | announces


Related News Stories From The Web And More

Related Bing News Search Results

Press Release: VYNE Therapeutics Announces Dosing of First Participants in Phase 1a Trial of Novel BD2-Selective BET Inhibitor VYN202 - Newscast

VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates

Thu, 07 Nov 2024 06:15:03 GMT VYNE Therapeutics Inc. (VYNE) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $1.85 per share a year ago. These ...

VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Thu, 07 Nov 2024 05:41:00 GMT VYN201 Phase 2b vitiligo trial exceeds enrollment target; Expected to be fully enrolled in December 2024 with top-line results on track for ...

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.

Fri, 25 Oct 2024 05:00:00 GMT For more information, please visit: www.acasti.com or www.gracetx.com. Statements in this press release that are not statements of historical or current fact constitute "forward-looking ...

Vyne Dental Announces Office Manager of the Year Award Winner

Wed, 16 Oct 2024 05:09:00 GMT "A special thanks to Vyne Dental for providing me with the tools that I need to keep our office running efficiently and with ease. Thank you for making this award possible." ...

Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market

Mon, 14 Oct 2024 17:00:00 GMT Seelos Therapeutics, Inc. is a clinical-stage ... Forward-Looking Statements: Statements made in this press release, which are not historical in nature, constitute forward-looking statements ...


Blow Us A Whistle